Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Pfizer Gets Rights to Sell Insulin from Biocon(2)

By Pharmaceutical Processing | October 18, 2010

 

NEW YORK (AP) — Pfizer Inc. has agreed to pay an initial $200
million to the Indian biotechnology company Biocon Ltd. for the right to sell
several of its insulin products used in the treatment of diabetes.

The world’s biggest drugmaker by revenue also agreed to pay Biocon as much as
$150 million more in development and regulatory milestone payments.

Pfizer, based in New York, said the deal gives it exclusive rights to sell
Biocon’s insulin and the generic version of several insulin products in most
countries.

Biocon makes recombinant human insulin, as well as generic versions of
Sanofi-Aventis SA’s insulin Lantus, Novo Nordisk AS’s NovoLog, and Eli Lilly and
Co.’s HumaLog. Its recombinant human insulin has been approved in 27 countries
and is on sale in 23. Its version of Lantus is being sold in India.

Pfizer said it will share marketing rights with Biocon in Germany, India, and
Malaysia. It will share the rights on some products with other companies that
have licensed products from Biocon.

Biocon will be responsible for development, manufacturing, and supply of the
insulin products, and will be responsible for getting regulatory approval.

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards